PDT Partners’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-64,769
Closed -$190K 858
2024
Q4
$190K Buy
64,769
+13,056
+25% +$53.6K 0.02% 663
2024
Q3
$244K Buy
+51,713
New +$233K 0.02% 631
2024
Q2
Sell
-26,793
Closed -$143K 751
2024
Q1
$143K Buy
+26,793
New +$126K 0.01% 595
2022
Q1
Sell
-35,543
Closed -$911K 1122
2021
Q4
$911K Buy
+35,543
New +$1.11M 0.07% 386

Other funds holding TSVT

PDT Partners's TSVT Position: Q1 2025 in Review

PDT Partners sold out of 2seventy bio (TSVT) in Q1 2025, closing a stake of 64,769 shares — an estimated $190K sold.

PDT Partners first reported a position in TSVT in Q4 2021 and held it in 4 quarters. The position peaked at $911K in Q4 2021. 139 funds tracked by Wall St. Rank hold TSVT as of Q1 2025.

  • PDT Partners reported no remaining 2seventy bio position as of Q1 2025 after selling out during the quarter.
  • PDT Partners sold 64,769 2seventy bio shares in Q1 2025, an estimated $190K.
  • PDT Partners first reported a position in 2seventy bio in Q4 2021 and held it in 4 quarters.
  • PDT Partners's 2seventy bio position peaked at $911K in Q4 2021.
  • 139 funds tracked by Wall St. Rank held 2seventy bio as of Q1 2025.

Based on PDT Partners's 13F filing for Q1 2025, filed 15 May 2025.